Successful Chemotherapy with Nab-Paclitaxel in a Heavily Treated Non-Small Cell Lung Cancer Patient: A Case Report

Non-small cell lung cancer (NSCLC) accounts for the majority of all lung cancers. A 69-year-old female with postoperatively recurrent NSCLC was treated weekly with nanoparticle-albumin-bound paclitaxel (nab-paclitaxel) monotherapy every 4 weeks as a tenth line chemotherapy, and stable disease was ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishihara, Mikiko, Igawa, Satoshi, Maki, Sachiyo, Harada, Shinya, Kusuhara, Seiichiro, Niwa, Hideyuki, Otani, Sakiko, Sasaki, Jiichiro, Jiang, Shi-Xu, Masuda, Noriyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2014
Materias:
Published online: June, 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107823/
https://www.ncbi.nlm.nih.gov/pubmed/25076891
http://dx.doi.org/10.1159/000364857

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107823/
https://www.ncbi.nlm.nih.gov/pubmed/25076891
http://dx.doi.org/10.1159/000364857

Ejemplares similares